Request Demo
Last update 26 Oct 2025
FPI-2053
Last update 26 Oct 2025
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms FPI-2053 |
Target |
Action modulators |
Mechanism EGFR modulators(Epidermal growth factor receptor erbB1 modulators), c-Met modulators(Hepatocyte growth factor receptor modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with FPI-2053NCT06147037
A Phase 1, First-in-human, Multicentre, Open-label, Dose Escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
100 Clinical Results associated with FPI-2053
Login to view more data
100 Translational Medicine associated with FPI-2053
Login to view more data
100 Patents (Medical) associated with FPI-2053
Login to view more data
100 Deals associated with FPI-2053
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic Colorectal Carcinoma | Phase 1 | United States | 31 Jul 2024 | |
| Metastatic Colorectal Carcinoma | Phase 1 | Canada | 31 Jul 2024 | |
| Non-Small Cell Lung Cancer | Phase 1 | United States | 31 Jul 2024 | |
| Non-Small Cell Lung Cancer | Phase 1 | Canada | 31 Jul 2024 | |
| Pancreatic Ductal Adenocarcinoma | Phase 1 | United States | 31 Jul 2024 | |
| Pancreatic Ductal Adenocarcinoma | Phase 1 | Canada | 31 Jul 2024 | |
| Renal Cell Carcinoma | Phase 1 | United States | 31 Jul 2024 | |
| Renal Cell Carcinoma | Phase 1 | Canada | 31 Jul 2024 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 1 | United States | 31 Jul 2024 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 1 | Canada | 31 Jul 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free